Found 6 matching trials
Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS PHASE3 The purpose of this study is to find out if cannabis-based medicine compare...
Show More Location
Multiple Sclerosis Program, Foothills Hospital SSB
Learn More & Join Trial
A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer PHASE3 The primary objective of this study was to evaluate the efficacy of nabixim...
Show More Location
Multiple Locations
Learn More & Join Trial
Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer PHASE3 This 9-week study aimed to determine the efficacy, safety and tolerability ...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis. PHASE3 The purpose of this study is to determine the effective dose range and to d...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS) PHASE3 The purpose of this study is to determine whether Sativex® versus Placebo i...
Show More Location
Department of Neurology, Northampton General Hospital
Learn More & Join Trial
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer PHASE3 This 9-week study aimed to determine the efficacy, safety, and tolerability...
Show More Location
Multiple Locations
Learn More & Join Trial